बावल (कोलोरेक्टल) कैंसर
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
कहाँ जाना है
इस trial के लिए 6 hospitals इन इंडिया में patients ले रहे हैं।
रजिस्ट्री समरी (तकनीकी)
The goal of this clinical trial is to evaluate whether Nuvastatic 300 capsule can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic 300 capsule significantly reduce cancer-related fatigue compared to placebo? Is Nuvastatic 300 capsule safe and well tolerated in this patient population? Researchers will compare Nuvastatic 300 capsule vs placebo to see if Nuvastatic 300 capsule improves fatigue scores and maintains an acceptable safety profile. Participants will: Receive Nuvastatic …
प्रायोजक: Natureceuticals Sdn Bhd
NCT07669454 on ClinicalTrials.gov
रजिस्ट्री पर आखिरी अपडेट 25 जून 2026 · हमने 20 अक्टूबर 2026 को पढ़ा